menu search

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm


Search within

Pages Search Results: